EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Yellow Fever - Pipeline Review, H1 2015

  • ID: 3259617
  • Report
  • April 2015
  • Region: Global
  • 56 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Arbovax, Inc.
  • iBio, Inc.
  • Johnson & Johnson
  • Myelo Therapeutics GmbH
  • Panacea Biotec Limited
  • Themis Bioscience GmbH
  • MORE
The report titled ‘Yellow Fever - Pipeline Review, H1 2015’ provides an overview of the Yellow Fever’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Yellow Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Yellow Fever and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Yellow Fever
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Yellow Fever and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Yellow Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Yellow Fever pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Yellow Fever
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Yellow Fever pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Arbovax, Inc.
  • iBio, Inc.
  • Johnson & Johnson
  • Myelo Therapeutics GmbH
  • Panacea Biotec Limited
  • Themis Bioscience GmbH
  • MORE
List of Tables
List of Figures
Introduction
REPORT COVERAGE
Yellow Fever Overview
Therapeutics Development
Pipeline Products for Yellow Fever - Overview
Pipeline Products for Yellow Fever - Comparative Analysis
Yellow Fever - Therapeutics under Development by Companies
Yellow Fever - Therapeutics under Investigation by Universities/Institutes
Yellow Fever - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Yellow Fever - Products under Development by Companies
Yellow Fever - Products under Investigation by Universities/Institutes
Yellow Fever - Companies Involved in Therapeutics Development
Adamas Pharmaceuticals, Inc.
Arbovax, Inc.
BioCryst Pharmaceuticals, Inc.
iBio, Inc.
Johnson & Johnson
Myelo Therapeutics GmbH
NewLink Genetics Corporation
Panacea Biotec Limited
Themis Bioscience GmbH
Yellow Fever - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ADS-324 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BCX-4430 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BG-323 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DiTU - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EMER-IT - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LCTA-949 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Myelo-001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit NS5 for Dengue and Flavivirus Infections - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever and arenavirus vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
yellow fever vaccine (YF17D) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Yellow Fever - Recent Pipeline Updates
Yellow Fever - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Yellow Fever, H1 2015
Number of Products under Development for Yellow Fever - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Yellow Fever - Pipeline by Adamas Pharmaceuticals, Inc., H1 2015
Yellow Fever - Pipeline by Arbovax, Inc., H1 2015
Yellow Fever - Pipeline by BioCryst Pharmaceuticals, Inc., H1 2015
Yellow Fever - Pipeline by iBio, Inc., H1 2015
Yellow Fever - Pipeline by Johnson & Johnson, H1 2015
Yellow Fever - Pipeline by Myelo Therapeutics GmbH, H1 2015
Yellow Fever - Pipeline by NewLink Genetics Corporation, H1 2015
Yellow Fever - Pipeline by Panacea Biotec Limited, H1 2015
Yellow Fever - Pipeline by Themis Bioscience GmbH, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Yellow Fever Therapeutics - Recent Pipeline Updates, H1 2015
Yellow Fever - Dormant Projects, H1 2015

List of Figures
Number of Products under Development for Yellow Fever, H1 2015
Number of Products under Development for Yellow Fever - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015
Note: Product cover images may vary from those shown
3 of 4
Adamas Pharmaceuticals, Inc.
Arbovax, Inc.
BioCryst Pharmaceuticals, Inc.
iBio, Inc.
Johnson & Johnson
Myelo Therapeutics GmbH
NewLink Genetics Corporation
Panacea Biotec Limited
Themis Bioscience GmbH
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll